1. Renda, Irene, Bianchi, Simonetta, Vezzosi, Vania, Tavella, Ketty, Susini, Tommaso. 2019. Expression of FGD3 gene as prognostic factor in young breast cancer patients. In Scientific reports, 9, 15204. doi:10.1038/s41598-019-51766-w. https://pubmed.ncbi.nlm.nih.gov/31645624/
2. Susini, Tommaso, Saccardin, Giulia, Renda, Irene, Pasqualini, Elisa, Bianchi, Simonetta. 2021. Immunohistochemical Evaluation of FGD3 Expression: A New Strong Prognostic Factor in Invasive Breast Cancer. In Cancers, 13, . doi:10.3390/cancers13153824. https://pubmed.ncbi.nlm.nih.gov/34359725/
3. Pasteris, N G, Nagata, K, Hall, A, Gorski, J L. . Isolation, characterization, and mapping of the mouse Fgd3 gene, a new Faciogenital Dysplasia (FGD1; Aarskog Syndrome) gene homologue. In Gene, 242, 237-47. doi:. https://pubmed.ncbi.nlm.nih.gov/10721717/
4. Guo, Feng, Cheng, Xiang, Jing, Boping, Wu, Heshui, Jin, Xin. 2022. FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression. In Oncogene, 41, 838-851. doi:10.1038/s41388-021-02140-6. https://pubmed.ncbi.nlm.nih.gov/34975151/
5. Willis, Scooter, Sun, Yuliang, Abramovitz, Mark, Brown, Myles, Leyland-Jones, Brian. 2017. High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers. In JCO precision oncology, 1, . doi:10.1200/PO.17.00009. https://pubmed.ncbi.nlm.nih.gov/32913979/
6. Xin, Cheng, Lai, Yi, Ji, Liqiang, Hong, Yonggang, Lou, Zheng. 2023. A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer. In Frontiers in genetics, 13, 1097234. doi:10.3389/fgene.2022.1097234. https://pubmed.ncbi.nlm.nih.gov/36704343/